Status:
COMPLETED
Improving Intermediate Risk Management. MARK Study
Lead Sponsor:
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborating Sponsors:
Preventive Services and Health Promotion Research Network
Conditions:
Myocardial Infarction
Angina Pectoris
Eligibility:
All Genders
35-74 years
Brief Summary
Cardiovascular risk functions fail to identify more than 50% of patients who develop cardiovascular disease. This is especially evident in the intermediate-risk patients in which clinical management b...
Detailed Description
Primary prevention of cardiovascular diseases is a priority in public health policy of developed and developing countries. The fundamental strategy consists in identifying people in a high risk situat...
Eligibility Criteria
Inclusion
- Population aged 35 to 74 which have an intermediate cardiovascular risk.
Exclusion
- Terminal illness or institutionalization at the appointment time
- Personal history of atherosclerotic disease
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
2495 Patients enrolled
Trial Details
Trial ID
NCT01428934
Start Date
July 1 2011
End Date
December 1 2016
Last Update
March 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unidad de Investigación en Atención Primaria de Girona, IDIAP Jordi Gol, Institut Català de la Salut
Girona, Spain, 17003